NCT04341740View on ClinicalTrials.gov

Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma

NATerminatedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

July 22, 2020

Primary Completion Date

March 9, 2021

Study Completion Date

April 9, 2021

Conditions

Renal Cell CarcinomaUrothelial Carcinoma

Interventions

PROCEDURE

Bone Marrow Aspirate

bone marrow aspiration

Trial Locations (1)

73104

Stephenson Cancer Center, Oklahoma City

Sponsors

Collaborators (1)

WindMIL Therapeutics

All Listed Sponsors

collaborator

WindMIL Therapeutics

INDUSTRY

lead

University of Oklahoma

OTHER

NCT04341740 - Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma | Biotech Hunter | Biotech Hunter